A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda

被引：0
作者：
Solomon J. Lubinga
Byamah B. Mutamba
Angelo Nganizi
Joseph B. Babigumira
机构：
[1] University of Washington,Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy
[2] University of Washington,Global Medicines Program, Department of Global Health
[3] Butabika National Referral Hospital for Mental,undefined
[4] Neurological and Substance Abuse Disorders,undefined
[5] Kadic Hospital,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Schizophrenia; Haloperidol; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：493 / 506
页数：13
相关论文
共 50 条
  • [31] Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
    Aigbogun, Myrlene S.
    Liu, Sizhu
    Kamat, Siddhesh A.
    Sapin, Christophe
    Duhig, Amy M.
    Citrome, Leslie
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 443 - 456
  • [32] Cost-effectiveness and Price of Aripiprazole for Schizophrenia in the Brazilian Public Health System
    Santos, Andre Soares
    Micaela de Souza Noronha, Kenya Valeria
    Andrade, Monica Viegas
    Ruas, Cristina Mariano
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2020, 23 (01) : 27 - 37
  • [33] A retrospective analysis of the effectiveness of antipsychotics in the treatment of ICU delirium
    Weaver, Cory B.
    Kane-Gill, Sandra L.
    Gunn, Scott R.
    Kirisci, Levent
    Smithburger, Pamela L.
    JOURNAL OF CRITICAL CARE, 2017, 41 : 234 - 239
  • [34] The effectiveness of long-acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia
    Fang, Su-Chen
    Liao, Ding-Lieh
    Huang, Cheng-Yi
    Hsu, Chun-Chi
    Cheng, Shu-Li
    Shao, Yu-Hsuan J.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2020, 35 (03)
  • [35] Cost-effectiveness of therapeutic interventions in schizophrenia
    Diaz-Castro, L.
    Cabello-Rangel, H.
    Arredondo, A.
    de Leon, E. Madrigal
    Pineda-Antunezc, C.
    EUROPEAN JOURNAL OF PSYCHIATRY, 2017, 31 (01) : 11 - 16
  • [36] Cost-Effectiveness of Positive Memory Training (PoMeT) for the Treatment of Depression in Schizophrenia
    Simon, Judit
    Kiss, Noemi
    Korrelboom, Kees
    Kingdon, David
    Wykes, Til
    Phiri, Peter
    van der Gaag, Mark
    Baksh, M. Fazil
    Steel, Craig
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [37] Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis
    Lin, Liang
    Zhao, Ying J.
    Zhou, Hui J.
    Khoo, Ai L.
    Teng, Monica
    Soh, Lay B.
    Lim, Boon P.
    Sim, Kang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (02) : 84 - 92
  • [38] Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain
    Einarson, Thomas R.
    Bereza, Basil G.
    Llinares, Ignacio Garcia
    Moro, Beatriz Gonzalez Martin
    Tedouri, Fadi
    Van Impe, Kristel
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1039 - 1047
  • [39] Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis
    Desamericq, G.
    Schurhoff, F.
    Meary, A.
    Szoeke, A.
    Macquin-Mavier, I.
    Bachoud-Levi, A. C.
    Maison, P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (02) : 127 - 134
  • [40] Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach
    Chopra, Avijeet S.
    Boskovic, Dusica Hadzi
    Kulkarni, Amit
    Cochran, Jeffrey M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 375 - 386
12345